Results for tag: "Adrenal Insufficiency Drug"

The Adrenal Insufficiency Drug market is a subset of the Endocrine and Metabolic Disorders Drugs market. Adrenal Insufficiency is a condition in which the adrenal glands do not produce enough of the hormones cortisol and aldosterone. Treatment for this condition typically involves the use of glucocorticoid and mineralocorticoid replacement therapy. These drugs are typically administered orally or via injection. The Adrenal Insufficiency Drug market is highly competitive, with a number of large pharmaceutical companies offering products. Some of the major players in the market include Pfizer, Merck, Novartis, Sanofi, and Eli Lilly. These companies offer a range of products, including hydrocortisone, prednisone, and dexamethasone. Show Less Read more